A Comparative Study of Vitamin D Levels and Some Biochemical Parameters between Healthy and Breast Cancer in Iraqi Females

Breast cancer is one of the most widespread cancers,depending on World Health Organization, cancer calculated for approximately 7.6 million incidences in 2008, whoever expected elevation in incidence is about 13.1 million in 2030. So that the current research investigates vitamin D role in the occurrence of this disease and explains if vitamin D has a positive effect on the incidence of disease, as well as measuring parathyroid hormone and estrogen levels. Three groups were included in this analysis: control healthy women, benign and malignant breast tumor women. All cases that were selected at the beginning of the disease diagnosis. According to statistical values vitamin D showed highly significant (P<0.001) decrease in benign (3.74±2.33) ng/ml and malignant (4.38±3.12) ng/ml tumor patients compared with healthy group (24.96±7.24) ng/ml. Also a high significant increase was shown for PTH values in benign (208.37±132.5) pg/ml and malignant (133.9±60.02)pg/ml tumor patients compared with healthy group (67.04±25.6) pg/ ml. Furthermore, results revealed non-significant difference in estrogen levels between benign group (54.11±22.93) pg/ml, and control group (64.85±22.18)pg/ml, while there were a significant difference in levels of estrogen between control and malignant tumor groups (52.4±18. 09) pg/ml. As a results, we found that all patients had sever vitamin D deficiency compared with healthy group, as well as high levels of parathyroid hormone as evidence of vitamin D deficiency, while estrogen levels where within normal levels. We concluded that all patient groups were suffering from vitamin D deficiency and elevation in parathyroid hormone that gives evidence of the role of vitamin D as anti-cancer agent.